Quadratus Lumborum Block for Total Hip Arthroplasty
This study is looking at how well a Quadratus Lumborum (QL) block, a type of nerve block, helps manage pain after total hip replacement surgery. Researchers want to see if a QL block using 0.25% ropivacaine (a local anesthetic) is more effective for pain relief than a QL block using saline (saltwater, acting as a placebo). They will measure your pain levels for up to 48 hours after surgery. You may be able to join if you are an adult undergoing elective primary total hip replacement surgery, do not have allergies to local anesthetics, peripheral neuropathy, or long-term opioid use. The study is currently enrolling 80 participants.
- Study design
- This interventional study will involve 80 participants who will be randomly assigned to receive either the active drug or a placebo. It is not specified which phase of testing this study is in.
- What's involved
- You would receive a QL block with either ropivacaine or saline. Your pain scores will be monitored for up to 48 hours after your surgery.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your pain scores will be followed for up to 48 hours after your surgery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Quadratus Lumborum Block for Total Hip Arthroplasty
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Pamela Chia, MD · PRINCIPAL_INVESTIGATOR · University of California, Los Angeles
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Pain scoreUp to 48 hrs post op
Pain scores will be assessed over 48hrs postop using the visual analog score